NANOVIBRONIX ANNOUNCES POSITIVE RESULTS FROM INDEPENENT, DOUBLE-BLIND TRIAL OF PAINSHIELDGlobeNewsWire • 10/11/21
NANOVIBRONIX ENTERS WORKER'S COMPENSATION MARKET THROUGH AGREEMENT WITH ORCHID MEDICALGlobeNewsWire • 09/29/21
NanoVibronix Reports Second Quarter 2021 Financial Results; Provides Business UpdateGlobeNewsWire • 08/16/21
NAOV Stock: Why Retail Investors Are Betting on a Big Squeeze for NanoVibronixInvestorPlace • 08/16/21
NANOVIBRONIX ANNOUNCES PLAN TO EXPAND PRODUCT PORTFOLIO WITH INTRODUCTION OF PAINSHIELD RELIEF FOR OVER-THE-COUNTER (OTC) USE AND PLANS FOR FUTURE PRODUCT LAUNCHGlobeNewsWire • 08/16/21
NANOVIBRONIX RECEIVES REGISTRATION APPROVAL FOR PAINSHIELD FROM TGA AUSTRALIAGlobeNewsWire • 08/11/21
NanoVibronix Applies For CMS Reimbursement Code For Its Ultrasound Devices In Efforts to Expand Addressable MarketBenzinga • 08/05/21